Home Spirometry

This policy addresses home spirometry/telespirometry for at‑home measurement of pulmonary function (FEV1, FVC, vital capacity and optional pulse oximetry) used for monitoring lung transplant recipients, heart‑lung transplant patients and other lung disease surveillance in patients generally aged ≥5 years. The policy considers home spirometry experimental/investigational and not covered for all indications; use is limited to FDA‑cleared devices with a physician prescription, is not intended for children under 5, and evidence is limited (small, observational studies, adherence issues), with the policy inactive for current claims adjudication.

"None — home monitoring of pulmonary function with a spirometer or telespirometer is considered experimental, investigational and/or unproven for all indications."

Sign up to see full coverage criteria, indications, and limitations.